| Date Filed | Type | Description |
| 05/28/2015 |
SC 13D/A
| Thomas, McNerney & Partners II L.P. has filed a Schedule 13D for Auspex Pharmaceuticals, Inc. |
| 05/14/2015 |
SC 13G/A
| Flynn James E reports a 0% stake in Auspex Pharmaceuticals, Inc. |
| 05/07/2015 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 490,069 shares
@ $0
Unknown transaction of 953,286 shares
@ $0
Unknown transaction of 1,182,943 shares
@ $0
Unknown transaction of 849,426 shares
@ $0
Unknown transaction of 973,379 shares
@ $0 |
|
| 05/07/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/06/2015 |
4
| GREER R SCOTT (Director) has filed a Form 4 on Auspex Pharmaceuticals, Inc. |
| 05/06/2015 |
4
| Sarshar Sepehr (Director) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 242,574 shares
@ $0 |
|
| 05/06/2015 |
4
| FERGUSON RODNEY A (Director) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 2,500,589 shares
@ $0 |
|
| 05/06/2015 |
4
| SCHNEIDER PHILLIP M (Director) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 13,333 options to buy
@ $12, valued at
$160k
Disposed/sold 6,667 options to buy
@ $18.13, valued at
$120.9k
|
|
| 05/06/2015 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on Auspex Pharmaceuticals, Inc. |
| 05/06/2015 |
4
| Bleil Lynn Dorsey (Director) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 20,000 options to buy
@ $18.13, valued at
$362.6k
|
|
| 05/06/2015 |
4
| Saks Samuel R (Chief Development Officer) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 67,338 shares
@ $0
Disposed/sold 7,777 options to buy
@ $0.9, valued at
$7k
Disposed/sold 47,777 options to buy
@ $0.86, valued at
$41.1k
Disposed/sold 27,235 options to buy
@ $0.86, valued at
$23.4k
Disposed/sold 30,000 options to buy
@ $59.66, valued at
$1.8M
Disposed/sold 15,000 restricted stock units
@ $0 |
|
| 05/06/2015 |
4
| CHOWRIRA BHARAT M (COO) has filed a Form 4 on Auspex Pharmaceuticals, Inc. |
| 05/06/2015 |
4
| Stamler David A (Chief Medical Officer) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 1,627 shares
@ $0
Disposed/sold 25,274 options to buy
@ $0.9, valued at
$22.7k
Disposed/sold 20,623 options to buy
@ $0.9, valued at
$18.6k
Disposed/sold 66,666 options to buy
@ $0.86, valued at
$57.3k
Disposed/sold 26,219 options to buy
@ $0.54, valued at
$14.2k
Disposed/sold 60,000 options to buy
@ $59.66, valued at
$3.6M
Disposed/sold 30,000 restricted stock units
@ $0 |
|
| 05/06/2015 |
4
| Schmid John P. (CFO) has filed a Form 4 on Auspex Pharmaceuticals, Inc. |
| 05/06/2015 |
4
| Shah Pratik (President and CEO) has filed a Form 4 on Auspex Pharmaceuticals, Inc. |
| 05/06/2015 |
4
| Zisson Alex (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc. |
| 05/05/2015 |
8-K
| Form 8-K - Current report |
| 05/05/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 05/05/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/24/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/24/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/23/2015 |
10-K/A
| Annual Report for the period ended December 31, 2014 [amend] |
| 04/20/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/20/2015 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/17/2015 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 04/10/2015 |
SC 13D
| INTEGRATED CORE STRATEGIES LLC reports a 5.9% stake in Auspex Pharmaceuticals, Inc. |
| 04/10/2015 |
SC 13G/A
| FMR LLC reports a 5.6% stake in AUSPEX PHARMACEUTICALS INC |
| 04/08/2015 |
SC 13D
| TEVA PHARMACEUTICAL INDUSTRIES LTD reports a 30% stake in Auspex Pharmaceuticals, Inc. |
| 04/07/2015 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 04/07/2015 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 04/06/2015 |
4
| CMEA Ventures VII LP (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc. |
| 03/31/2015 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 03/30/2015 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 03/30/2015 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
|